- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/74 - Thrombin
Patent holdings for IPC class C12N 9/74
Total number of patents in this class: 164
10-year publication summary
|
15
|
6
|
8
|
13
|
9
|
10
|
9
|
7
|
5
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Omrix Biopharmaceuticals Ltd. | 153 |
19 |
| Gladiator Biosciences, Inc. | 14 |
10 |
| Ethicon, Inc. | 1174 |
6 |
| Saint Louis University | 296 |
6 |
| Absci Corporation | 86 |
5 |
| Baxter International Inc. | 2411 |
4 |
| Arthrex, Inc. | 1422 |
4 |
| Guangzhou Bioseal Biotech Co., Ltd. | 31 |
4 |
| Absci, LLC | 10 |
3 |
| Aronora, Inc. | 15 |
3 |
| Osaka University | 3385 |
3 |
| Siemens Healthcare Diagnostics Products GmbH | 148 |
3 |
| SomaLogic Operating Co., Inc. | 252 |
3 |
| Massachusetts Institute of Technology | 10093 |
2 |
| Bio Products Laboratory Limited | 31 |
2 |
| Biomet Biologics, LLC | 77 |
2 |
| Canadian Blood Services | 78 |
2 |
| Cleveland State University | 76 |
2 |
| In2cure AB | 13 |
2 |
| Mcmaster University | 807 |
2 |
| Other owners | 77 |